Concepedia

Amy Templeman

AT

Statistics

Publications

4

Citations

89

H-Index

4

Active since

2014

Affiliations

Queen's University Belfast(Current)

Almac (United Kingdom)

Amy Templeman is an author at Queen's University Belfast specializing in oncology, drug design, and drug discovery.

ORCID

Publications per year

2014–2023

4

Publications

4

TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancers

Alexander J. McIntyre, Charlotte Zoe Angel, James S. Smith et al. · Nucleic Acids Research · 2022 · 29 citations · Full text

, , +15

Analytical performance of the FDA-cleared Parsortix® PC1 system

Amy Templeman, Michael Craig Miller, Martin J. Cooke et al. · Journal of Circulating Biomarkers · 2023 · 29 citations · Full text

, , +17

Development of a potent and selective cell penetrant Legumain inhibitor

Kerry A. Ness, Sharon L. Eddie, Catherine Higgins et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 19 citations · Full text

, , +7

P3 SAR exploration of biphenyl carbamate based Legumain inhibitors

Catherine Higgins, Samira Bouazzaoui, Kishore K.D. Gaddale et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 12 citations · Full text

, , +14

1–4 of 4